Abstract
Higher-grade gliomas are distinguished by increased vascular endothelial cell proliferation and peritumoral edema. These are thought to be instigated by vascular endothelial growth factor, which in turn is regulated by cellular oxygen tension. Hypoxia inducible factor-1α (HIF-1α) is a main responder to intracellular hypoxia and is overexpressed in many human cancers, including gliomas. Here we present methods for investigating the role of HIF-1α in glioma growth in vivo and in vitro using RNA interference in U251, U87, and U373 glioma cells.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Zhong, H., De Marzo, A. M., Laughner, E., Lim, M., Hilton, D. A., Zagzag, D., Buechler, P., Isaacs, W. B., Semenza, G. L., and Simons, J. W. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res 59, 5830–5835.
Kaur, B., Khwaja, F. W., Severson, E. A., Matheny, S. L., Brat, D. J., and Van Meir, E. G. (2005) Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis. Neurooncol 7, 134–153.
Vaupel, P., Thews, O., and Hoeckel, M. (2001) Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18, 243–259.
Maxwell, P. H., Dachs, G. U., Gleadle, J. M., Nicholls, L. G., Harris, A. L., Stratford, I. J., Hankinson, O., Pugh, C. W., and Ratcliffe, P. J. (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A 94, 8104–8109.
Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M., and Johnson, R. S. (2000) Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res 60, 4010–4015.
Zagzag, D., Zhong, H., Scalzitti, J. M., Laughner, E., Simons, J. W., and Semenza, G. L. (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer 88, 2606–2618.
Jensen, R. L., Ragel, B. T., Whang, K., and Gillespie, D. (2006) Inhibition of hypoxia inducible factor-1alpha (HIF-1alpha) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas. J Neurooncol 78, 233–247.
Gillespie, D. L., Whang, K., Ragel, B. T., Flynn, J. R., Kelly, D. A., and Jensen, R. L. (2007) Silencing of hypoxia inducible factor-1alpha by RNA interference attenuates human glioma cell growth in vivo. Clin Cancer Res 13, 2441–2448.
Li, L., Lin, X., Staver, M., Shoemaker, A., Semizarov, D., Fesik, S. W., and Shen, Y. (2005) Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo. Cancer Res 65, 7249–7258.
Rapisarda, A., Zalek, J., Hollingshead, M., Braunschweig, T., Uranchimeg, B., Bonomi, C. A., Borgel, S. D., Carter, J. P., Hewitt, S. M., Shoemaker, R. H., and Melillo, G. (2004) Schedule-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts. Cancer Res 64, 6845–6848.
Semenza, G. L. (1999) Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15, 551–578.
Richard, D. E., Berra, E., and Pouyssegur, J. (1999) Angiogenesis: how a tumor adapts to hypoxia. Biochem Biophys Res Commun 266, 718–722.
Wang, G. L., Jiang, B. H., Rue, E. A., and Semenza, G. L. (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci U S A 92, 5510–5514.
Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. (1996) Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16, 4604–4613.
Warburg, O. (1956) On the origin of cancer cells. Science 123, 309–314.
Robey, I. F., Lien, A. D., Welsh, S. J., Baggett, B. K., and Gillies, R. J. (2005) Hypoxia-inducible factor-1alpha and the glycolytic phenotype in tumors. Neoplasia 7, 324–330.
Xu, R. H., Pelicano, H., Zhou, Y., Carew, J. S., Feng, L., Bhalla, K. N., Keating, M. J., and Huang, P. (2005) Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia. Cancer Res 65, 613–621.
Lu, H., Forbes, R. A., and Verma, A. (2002) Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis. J Biol Chem 277, 23111–23115.
Kendler, A., and Dawson, G. (1990) Progressive hypoxia inhibits the de novo synthesis of galactosylceramide in cultured oligodendrocytes. J Biol Chem 265, 12259–12266.
Steinbach, J. P., Wolburg, H., Klumpp, A., Probst, H., and Weller, M. (2003) Hypoxia-induced cell death in human malignant glioma cells: energy deprivation promotes decoupling of mitochondrial cytochrome c release from caspase processing and necrotic cell death. Cell Death Differ 10, 823–832.
Cullen, B. R. (2006) Enhancing and confirming the specificity of RNAi experiments. Nat Methods 3, 677–681.
Yeung, H. Y., Lai, K. P., Chan, H. Y., Mak, N. K., Wagner, G. F., and Wong, C. K. (2005) Hypoxia-inducible factor-1-mediated activation of stanniocalcin-1 in human cancer cells. Endocrinology 146, 4951–4960.
Lassus, P., Rodriguez, J., and Lazebnik, Y. (2002) Confirming specificity of RNAi in mammalian cells. Sci STKE 2002, PL13.
Tan, C., de Noronha, R. G., Roecker, A. J., Pyrzynska, B., Khwaja, F., Zhang, Z., Zhang, H., Teng, Q., Nicholson, A. C., Giannakakou, P., Zhou, W., Olson, J. J., Pereira, M. M., Nicolaou, K. C., and Van Meir, E. G. (2005) Identification of a novel small-molecule inhibitor of the hypoxia-inducible factor 1 pathway. Cancer Res 65, 605–612.
Chau, N. M., Rogers, P., Aherne, W., Carroll, V., Collins, I., McDonald, E., Workman, P., and Ashcroft, M. (2005) Identification of novel small molecule inhibitors of hypoxia-inducible factor-1 that differentially block hypoxia-inducible factor-1 activity and hypoxia-inducible factor-1alpha induction in response to hypoxic stress and growth factors. Cancer Res 65, 4918–4928.
Pansare, V., Munkarah, A. R., Schimp, V., Haitham Arabi, M., Saed, G. M., Morris, R. T., and Ali-Fehmi, R. (2007) Increased expression of hypoxia-inducible factor 1alpha in type I and type II endometrial carcinomas. Mod Pathol 20, 35–43.
Jensen, R.L., Leppla, D., Rokosz, N., and Wurster, R.D. (1998) Matrigel augments xenograft transplantation of meningioma cells into athymic mice. Neurosurgery 42, 130–135; discussion 35–36.
Wang, X. L., Nguyen, T., Gillespie, D., Jensen, R., and Lu, Z. R. (2008) A multifunctional and reversibly polymerizable carrier for efficient siRNA delivery. Biomaterials 29, 15–22.
Acknowledgments°We thank Kristin Kraus for her excellent editorial guidance.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Humana Press, a part of Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Gillespie, D. et al. (2009). Silencing of HIF-1α by RNA Interference in Human Glioma Cells In Vitro and In Vivo. In: Sioud, M. (eds) siRNA and miRNA Gene Silencing. Methods in Molecular Biology, vol 487. Humana Press. https://doi.org/10.1007/978-1-60327-547-7_14
Download citation
DOI: https://doi.org/10.1007/978-1-60327-547-7_14
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60327-546-0
Online ISBN: 978-1-60327-547-7
eBook Packages: Springer Protocols